The protein cargo of HDL: implications for vascular wall biology and therapeutics

Jay W Heinecke1

  • 1Department of Medicine, University of Washington, Seattle, WA 98195, USA. heinecke@u.washington.edu

Insights

High-density lipoprotein (HDL) may protect against atherosclerosis through cholesterol transport and anti-inflammatory actions. However, HDL-cholesterol levels alone do not fully predict its heart-protective benefits, suggesting a need to explore HDL

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • High-density lipoprotein (HDL) is implicated in inhibiting atherosclerosis.
  • Key proposed mechanisms include reverse cholesterol transport and anti-inflammatory effects.
  • Current metrics like HDL-cholesterol (HDL-C) levels may not fully capture HDL's cardioprotective functions.

Purpose of the Study:

  • To review current understanding of HDL's functional and cardioprotective roles.
  • To explore the significance of the HDL proteome in HDL's biological activities.
  • To highlight limitations of solely quantifying HDL-C for assessing cardiovascular risk.

Main Methods:

  • Literature review of existing studies on HDL function and atherosclerosis.
  • Analysis of research on HDL's anti-inflammatory and cholesterol efflux pathways.
  • Examination of proteomic studies investigating HDL composition.

Main Results:

  • HDL exerts cardioprotective effects through multiple pathways beyond cholesterol transport.
  • The protein composition (proteome) of HDL is critical for its functional capacity.
  • HDL-C levels alone are insufficient indicators of HDL's atheroprotective potential.

Conclusions:

  • HDL's role in cardiovascular health is complex and multifaceted.
  • Understanding the HDL proteome is essential for a comprehensive assessment of its cardioprotective effects.
  • Future research should focus on functional assays and proteomic analysis over simple HDL-C quantification.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support variousĀ  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...